Fig. 2
Survival outcomes. A The 18-month local recurrence rate is 14%. B The 18-month distant metastases rate is 39%. C The 18-month overall survival rate is 85%. D The 18-month disease-free survival rate is 55%.
Fig. 2 | Annals of Surgical Oncology
Survival outcomes. A The 18-month local recurrence rate is 14%. B The 18-month distant metastases rate is 39%. C The 18-month overall survival rate is 85%. D The 18-month disease-free survival rate is 55%.